CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Elkington And Fife against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Enantiomers Of Tetrahydro-N,N-Dimethyl-2,2-Diphenyl-3-Furanmethanamine (Anavex2-73) And Use Thereof In The Treatment Of Alzheimer'S Disease And Other Disorders Modulated By The Sigma 1 ReceptorANAVEX LIFE SCIENCESJun 12, 2025
Aprocitentan For Use In The Treatment Of Hypertension And Related Diseases In Combination With Angiotensin Converting Enzyme Inhibitor (Ace) Or Angiotensin Receptor Blocker (Arb)IDORSIA PHARMACEUTICALSMay 29, 2025
Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin TherapyAMARIN PHARMACEUTICALS IRELANDMay 9, 2025
Nasal Delivery DevicesOPTINOSEApr 10, 2025
Methods For Ensuring Resuspension Of Paliperidone Palmitate FormulationsJANSSEN PHARMACEUTICAFeb 14, 2025
Methods Of Reducing The Risk Of Cardiovascular Events In A SubjectAMARIN PHARMACEUTICALS IRELANDJan 24, 2025
Novel Pharmaceutical CompositionNOVARTISJan 10, 2025
Compositions, Methods And Systems For Aerosol Drug DeliveryASTRAZENECA PHARMACEUTICALS LPJan 9, 2025
Compositions, Methods And Systems For Aerosol Drug DeliveryASTRAZENECA PHARMACEUTICALS LPJan 9, 2025
Pharmaceutical Composition, Pharmaceutical Dosage Form, Process For Their Preparation, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMJan 8, 2025

Top competitors of Elkington And Fife

List of top competitors of Elkington And Fife based on patent oppositions.